RÉSUMÉ
Introduction: Polyarticular juvenile idiopathic arthritis (pJIA) is a childhood-onset autoimmune disease. Immune cells contribute to persistent inflammation observed in pJIA. Despite the crucial role of monocytes in arthritis, the precise involvement of classical monocytes in the pathogenesis of pJIA remains uncertain. Here, we aimed to uncover the transcriptomic patterns of classical monocytes in pJIA, focusing on their involvement in disease mechanism and heterogeneity. Methods: A total of 17 healthy subjects and 18 premenopausal women with pJIA according to ILAR criteria were included. Classical monocytes were isolated, and RNA sequencing was performed. Differential expression analysis was used to compare pJIA patients and healthy control group. Differentially expressed genes (DEGs) were identified, and gene set enrichment analysis (GSEA) was performed. Using unsupervised learning approach, patients were clustered in two groups based on their similarities at transcriptomic level. Subsequently, these clusters underwent a comparative analysis to reveal differences at the transcriptomic level. Results: We identified 440 DEGs in pJIA patients of which 360 were upregulated and 80 downregulated. GSEA highlighted TNF-α and IFN-γ response. Importantly, this analysis not only detected genes targeted by pJIA therapy but also identified new modulators of immuno-inflammation. PLAUR, IL1B, IL6, CDKN1A, PIM1, and ICAM1 were pointed as drivers of chronic hyperinflammation. Unsupervised learning approach revealed two clusters within pJIA, each exhibiting varying inflammation levels. Conclusion: These findings indicate the pivotal role of immuno-inflammation driven by classical monocytes in pJIA and reveals the existence of two subclusters within pJIA, regardless the positivity of rheumatoid factor and anti-CCP, paving the way to precision medicine.
Sujet(s)
Arthrite juvénile , Analyse de profil d'expression de gènes , Inflammation , Monocytes , Transcriptome , Adulte , Enfant , Femelle , Humains , Anticorps anti-protéines citrullinées , Arthrite juvénile/classification , Arthrite juvénile/génétique , Arthrite juvénile/immunologie , Arthrite juvénile/anatomopathologie , Études cas-témoins , Maladie chronique , Analyse de regroupements , Inflammation/génétique , Inflammation/immunologie , Inflammation/anatomopathologie , Médiateurs de l'inflammation/immunologie , Interféron gamma/immunologie , Monocytes/immunologie , Monocytes/métabolisme , Phénotype , Médecine de précision , Préménopause , Liaison aux protéines , Cartes d'interactions protéiques , Facteur rhumatoïde , Analyse de séquence d'ARN , Transcriptome/génétique , Facteur de nécrose tumorale alpha/immunologie , Apprentissage machine non superviséRÉSUMÉ
The innate and acquired immune response induced by a commercial inactivated vaccine against Bovine Herpesvirus-1 (BoHV-1) and protection conferred against the virus were analyzed in cattle. Vaccination induced high levels of BoHV-1 antibodies at 30, 60, and 90 days post-vaccination (dpv). IgG1 and IgG2 isotypes were detected at 90 dpv, as well as virus-neutralizing antibodies. An increase of anti-BoHV-1 IgG1 in nasal swabs was detected 6 days post-challenge in vaccinated animals. After viral challenge, lower virus excretion and lower clinical score were observed in vaccinated as compared to unvaccinated animals, as well as BoHV-1-specific proliferation of lymphocytes and production of IFNγ, TNFα, and IL-4. Downregulation of the expression of endosome Toll-like receptors 8-9 was detected after booster vaccination. This is the first thorough study of the immunity generated by a commercial vaccine against BoHV-1 in cattle.
Sujet(s)
Anticorps neutralisants/biosynthèse , Herpèsvirus bovin de type 1/immunologie , Vaccins contre les herpèsvirus/administration et posologie , Immunoglobuline G/biosynthèse , Rhinotrachéite infectieuse bovine/prévention et contrôle , Récepteur de type Toll-8/immunologie , Récepteur-9 de type Toll-like/immunologie , Immunité acquise/effets des médicaments et des substances chimiques , Animaux , Anticorps antiviraux , Bovins , Prolifération cellulaire , Endosomes/immunologie , Endosomes/métabolisme , Expression des gènes , Herpèsvirus bovin de type 1/pathogénicité , Immunité innée/effets des médicaments et des substances chimiques , Rappel de vaccin/méthodes , Rhinotrachéite infectieuse bovine/génétique , Rhinotrachéite infectieuse bovine/immunologie , Rhinotrachéite infectieuse bovine/virologie , Interféron gamma/génétique , Interféron gamma/immunologie , Interleukine-4/génétique , Interleukine-4/immunologie , Lymphocytes/immunologie , Lymphocytes/virologie , Mâle , Fosse nasale/immunologie , Fosse nasale/virologie , Récepteur de type Toll-8/agonistes , Récepteur de type Toll-8/génétique , Récepteur-9 de type Toll-like/agonistes , Récepteur-9 de type Toll-like/génétique , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologie , Vaccination/méthodes , Vaccins inactivésRÉSUMÉ
Background: Leishmaniasis is a neglected arthropod-borne disease that affects millions of people worldwide. Successful Leishmania infections require the mitigation of immune cell functions leading to parasite survival and proliferation. A large body of evidence highlights the involvement of neutrophils (PMNs) and dendritic cells (DCs) in the establishment of immunological responses against these parasites. However, few studies, contemplate to what extent these cells interact synergistically to constrain Leishmania infection. Objective: We sought to investigate how PMNs and infected DCs interact in an in vitro model of Leishmania amazonensis infection. Material and Methods: Briefly, human PMNs and DCs were purified from the peripheral blood of healthy donors. Next, PMNs were activated with fibronectin and subsequently co-cultured with L. amazonensis-infected DCs. Results: We observed that L. amazonensis-infected DC exhibited lower rates of infection when co-cultivated with either resting or activated PMNs. Surprisingly, we found that the release of neutrophil enzymes was not involved in Leishmania killing. Next, we showed that the interaction between PMNs and infected-DCs was intermediated by DC-SIGN, further suggesting that parasite elimination occurs in a contact-dependent manner. Furthermore, we also observed that TNFα and ROS production was dependent on DC-SIGN-mediated contact, as well as parasite elimination is dependent on TNFα production in the co-culture. Finally, we observed that direct contact between PMNs and DCs are required to restore the expression of DC maturation molecules during L. amazonensis infection. Conclusion: Our findings suggest that the engagement of direct contact between PMNs and L. amazonensis-infected DC via DC-SIGN is required for the production of inflammatory mediators with subsequent parasite elimination and DC maturation.
Sujet(s)
Molécules d'adhérence cellulaire/immunologie , Cellules dendritiques/immunologie , Lectines de type C/immunologie , Leishmaniose/immunologie , Granulocytes neutrophiles/immunologie , Récepteurs de surface cellulaire/immunologie , Différenciation cellulaire , Cellules cultivées , Techniques de coculture , Humains , Leishmania , Leishmaniose/parasitologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Overproduction of inflammatory cytokines is a keystone event in COVID-19 pathogenesis; TNF and its receptors (TNFR1 and TNFR2) are critical pro-inflammatory molecules. ADAM17 releases the soluble (sol) forms of TNF, TNFR1, and TNFR2. This study evaluated TNF, TNFRs, and ADAM17 at the protein, transcriptional, and gene levels in COVID-19 patients with different levels of disease severity. In total, 102 patients were divided into mild, moderate, and severe condition groups. A group of healthy donors (HD; n = 25) was included. Our data showed that solTNFR1 and solTNFR2 were elevated among the COVID-19 patients (p < 0.0001), without increasing the transcriptional level. Only solTNFR1 was higher in the severe group as compared to the mildly ill (p < 0.01), and the level was higher in COVID-19 patients who died than those that survived (p < 0.0001). The solTNFR1 level had a discrete negative correlation with C-reactive protein (p = 0.006, Rho = -0.33). The solADAM17 level was higher in severe as compared to mild disease conditions (p < 0.01), as well as in COVID-19 patients who died as compared to those that survived (p < 0.001). Additionally, a potential association between polymorphism TNFRSF1A:rs767455 and a severe degree of disease was suggested. These data suggest that solTNFR1 and solADAM17 are increased in severe conditions. solTNFR1 should be considered a potential target in the development of new therapeutic options.
Sujet(s)
Protéine ADAM17 , COVID-19/immunologie , Récepteur au facteur de nécrose tumorale de type I , Facteur de nécrose tumorale alpha , Protéine ADAM17/sang , Protéine ADAM17/immunologie , Adulte , Sujet âgé , Études cas-témoins , Études de cohortes , Femelle , Humains , Mâle , Adulte d'âge moyen , Récepteur au facteur de nécrose tumorale de type I/sang , Indice de gravité de la maladie , Facteur de nécrose tumorale alpha/sang , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Monocyte recruitment and activation of macrophages are essential for homeostasis but are also related to the development and progression of cardiometabolic diseases. The management of inflammation with dietary components has been widely investigated. Two components that may influence inflammation are unsaturated fatty acids such as oleic acid (OA; 18:1cis-9) and antioxidant compounds like anthocyanins. Molecular and metabolic effects of such bioactive compounds are usually investigated in isolation, whereas they may be present in combination in foods or the diet. Considering this, we aimed to analyze the effects of OA and the anthocyanin keracyanin (AC) alone and in combination on toll-like receptor-mediated inflammatory responses in monocytes and macrophages. For this, THP-1-derived macrophages and monocytes were exposed to 3 treatments: OA, AC, or the combination (OAAC) and then stimulated with lipopolysaccharide. Inflammation-related gene expression and protein concentrations of IL-1ß, TNF-α, IL-6, MCP-1, and IL-10 were assessed. Also, NFκBp65, IκBα, and PPAR-γ protein expression were determined. OA, AC, and OAAC decreased pNFκBp65, PPARγ, IκBα, TNF-α, IL-1ß, IL-6, and MCP-1 and increased IL-10. MCP-1 protein expression was lower with OAAC than with either OA and AC alone. Compared to control, OAAC decreased mRNA for TLR4, IκKα, IκBα, NFκB1, MCP-1, TNF-α, IL-6, and IL-1ß more than OA or AC did alone. Also, IL-10 mRNA was increased by OAAC compared with control, OA, and AC. In summary, OA and AC have anti-inflammatory effects individually but their combination (OAAC) exerts a greater effect.
Sujet(s)
Anthocyanes/pharmacologie , Anti-inflammatoires/pharmacologie , Inflammation/immunologie , Macrophages/effets des médicaments et des substances chimiques , Monocytes/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/immunologie , Acide oléique/pharmacologie , Lignée cellulaire , Synergie des médicaments , Humains , Inflammation/traitement médicamenteux , Inflammation/génétique , Interleukine-1 bêta/génétique , Interleukine-1 bêta/immunologie , Macrophages/immunologie , Monocytes/immunologie , Inhibiteur alpha de NF-KappaB/génétique , Inhibiteur alpha de NF-KappaB/immunologie , Facteur de transcription NF-kappa B/génétique , Récepteur PPAR gamma/génétique , Récepteur PPAR gamma/immunologie , Récepteur de type Toll-4/génétique , Récepteur de type Toll-4/immunologie , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory disease that mainly affects the axial and sacroiliac joints. Single-nucleotide polymorphisms (SNPs) in genes encoding cytokines have been associated with AS, which can interfere with the production of these cytokines and contribute to the development of AS. In order to contribute to a better understanding of the pathology of AS, our objective was to investigate a possible association of the IL10 -1082 A>G SNP (rs1800896) with AS and to evaluate the serum levels of TNF-α, IL-10, IL-17A, and IL-17F in AS patients and controls comparing them with their respective genotypes (TNF rs1800629, IL10 rs1800896, IL17A rs2275913, and IL17F rs763780). Patients and controls were selected from the Maringá University Hospital and the Maringá Rheumatism Clinic, in Paraná State, Southern Brazil, and they were diagnosed by the ASAS Criteria. In total, 149 patients and 169 controls were genotyped for the IL10 -1082 A>G polymorphism using a polymerase chain reaction with sequence specific primers (PCR-SSP); the measurement of TNF-α serum levels was performed through the immunofluorimetric test and IL-10, IL-17A, and IL-17F using an ELISA test. There was a high frequency of the IL10 -1082 G allele in AS patients compared with controls with an odds ratio of 1.83 and 95% confidence interval of 1.32 to 2.54, and a significant difference in the genotype frequencies of the IL10 -1082 A/G+G/G between patients and healthy controls, with an odds ratio of 3.01 and 95% confidence interval of 1.75 to 5.17. In addition, increased serum levels of IL-10 were observed in AS patients: 2.38 (IQR, 0.91) pg/ml compared with controls 1.72 (IQR 0.93) pg/ml (P = 0.01). Our results also showed an association between IL17F rs763780 C/T+T/T genotypes and increased serum levels of IL-17F in patients with AS and also in controls. We can conclude that patients with the A/G and G/G genotypes for -1082 A>G (rs1800896) in the IL10 gene are three times more likely to develop AS, that the serum level of IL-10 was higher in AS patients and that the IL17F rs763780 polymorphism can affect the levels of IL-17F in the serum of patients and controls in the same way.
Sujet(s)
Prédisposition génétique à une maladie , Interleukine-10/génétique , Pelvispondylite rhumatismale/génétique , Adulte , Allèles , Brésil , Études cas-témoins , Femelle , Fréquence d'allèle , Humains , Interleukine-10/sang , Interleukine-10/immunologie , Interleukine-17/sang , Interleukine-17/immunologie , Mâle , Adulte d'âge moyen , Polymorphisme de nucléotide simple , Pelvispondylite rhumatismale/sang , Pelvispondylite rhumatismale/immunologie , Facteur de nécrose tumorale alpha/sang , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Zika virus (ZIKV) is an emerging arbovirus with recent global expansion. Historically, ZIKV infections with Asian lineages have been associated with mild disease such as rash and fever. However, recent Asian sub-lineages have caused outbreaks in the South Pacific and Latin America with increased prevalence of neurological disorders in infants and adults. Asian sub-lineage differences may partially explain the range of disease severity observed. However, the effect of Asian sub-lineage differences on pathogenesis remains poorly characterized. Current study conducts a head-to-head comparison of three Asian sub-lineages that are representative of the circulating ancestral mild Asian strain (ZIKV-SG), the 2007 epidemic French Polynesian strain (ZIKV-FP), and the 2013 epidemic Brazil strain (ZIKV-Brazil) in adult Cynomolgus macaques. Animals infected intervenously or subcutaneously with either of the three clinical isolates showed sub-lineage-specific differences in viral pathogenesis, early innate immune responses and systemic inflammation. Despite the lack of neurological symptoms in infected animals, the epidemiologically neurotropic ZIKV sub-lineages (ZIKV-Brazil and/or ZIKV-FP) were associated with more sustained viral replication, higher systemic inflammation (i.e. higher levels of TNFα, MCP-1, IL15 and G-CSF) and greater percentage of CD14+ monocytes and dendritic cells in blood. Multidimensional analysis showed clustering of ZIKV-SG away from ZIKV-Brazil and ZIKV-FP, further confirming sub-lineage differences in the measured parameters. These findings highlight greater systemic inflammation and monocyte recruitment as possible risk factors of adult ZIKV disease observed during the 2007 FP and 2013 Brazil epidemics. Future studies should explore the use of anti-inflammatory therapeutics as early treatment to prevent ZIKV-associated disease in adults.
Sujet(s)
Immunité innée , Infection par le virus Zika/immunologie , Virus Zika/classification , Virus Zika/immunologie , Virus Zika/pathogénicité , Adulte , Animaux , Asie , Brésil , Cellules dendritiques/immunologie , Modèles animaux de maladie humaine , Humains , Interleukine-15/génétique , Interleukine-15/immunologie , Macaca fascicularis/immunologie , Macaca fascicularis/virologie , Monocytes/immunologie , Spécificité d'espèce , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologie , Virulence , Réplication virale , Virus Zika/génétique , Infection par le virus Zika/virologieRÉSUMÉ
Pharyngitis and tonsillitis are the most common acute respiratory infections (ARIs) in children aged ≤5 years. The analysis of published data showed that some probiotics could decrease the frequency and number of days with ARIs. This study evaluated the safety and efficacy of Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 to reduce the duration and severity of ARI symptoms. This randomised controlled trial included children aged from 6 months to 5 years, with pharyngitis or tonsillitis, who were randomised to receive a probiotic product containing L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938 or placebo, as drops, ingested orally for 10 days as adjuvants to the use of non-steroidal anti-inflammatory drugs. The main outcomes were the duration and severity of ARI symptoms. The secondary outcomes were changes in salivary immunoglobulin A and inflammatory biomarkers. There was no fever on day 2 and subsequent days in the L. reuteri group (37.3 ±0.5 °C vs 38.6±0.3 °C, P<0.05). Beginning on day 3, the severity of sore throat (5±0.9 vs 8±1.2, P<0.05) was lower in the L. reuteri group. Significant differences in the days with runny nose, nasal congestion, days of non-programmed visits to the medical office or emergency department, levels in tumoral necrosis factor-alpha (TNF-alpha) and related costs of treatment were observed in the L. reuteri group. The frequency of adverse events was similar between the groups. Therefore, L. reuteri ATCC PTA 5289 combined with L. reuteri DSM 17938 is a safe and effective adjunct to reduce the symptoms of pharyngitis or tonsillitis in children.
Sujet(s)
Limosilactobacillus reuteri/physiologie , Pharyngite/traitement médicamenteux , Probiotiques/administration et posologie , Amygdalite/traitement médicamenteux , Enfant d'âge préscolaire , Femelle , Humains , Immunoglobuline A/immunologie , Nourrisson , Mâle , Pharyngite/immunologie , Salive/immunologie , Amygdalite/immunologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
BACKGROUND: Recently developed immunosuppressive drugs, especially TNF antagonists, may enhance the risk of granulomatous infections, including leprosy. We aimed to evaluate the leprosy detection rate in patients under immunosuppression due to rheumatological, dermatological and gastroenterological diseases. METHODS: We performed a systematic review of the literature by searching the PubMed, EMBASE, LILACS, Web of Science and Scielo databases through 2018. No date or language restrictions were applied. We included all articles that reported the occurrence of leprosy in patients under medication-induced immunosuppression. RESULTS: The search strategy resulted in 15,103 articles; finally, 20 articles were included, with 4 reporting longitudinal designs. The detection rate of leprosy ranged from 0.13 to 116.18 per 100,000 patients/year in the USA and Brazil, respectively. In the meta-analysis, the detection rate of cases of leprosy per 100,000 immunosuppressed patients with rheumatic diseases was 84 (detection rate = 0.00084; 95% CI = 0.0000-0.00266; I2 = 0%, p = 0.55). CONCLUSION: Our analysis showed that leprosy was relatively frequently detected in medication-induced immunosuppressed patients suffering from rheumatological diseases, and further studies are needed. The lack of an active search for leprosy in the included articles precluded more precise conclusions. TRIAL REGISTRATION: This review is registered in PROSPERO with the registry number CRD42018116275 .
Sujet(s)
Maladies gastro-intestinales/traitement médicamenteux , Immunosuppresseurs/usage thérapeutique , Lèpre/diagnostic , Rhumatismes/traitement médicamenteux , Maladies de la peau/traitement médicamenteux , Maladies gastro-intestinales/anatomopathologie , Humains , Immunosuppresseurs/effets indésirables , Lèpre/étiologie , Études longitudinales , Rhumatismes/anatomopathologie , Maladies de la peau/anatomopathologie , Facteur de nécrose tumorale alpha/antagonistes et inhibiteurs , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Heat stress is one of the environmental factors that most severely affects milk industry, as it has impact on production, immune responses and reproductive performance. The present study was conducted with high-performance Holando-Argentino cows. Our objective was to study TNF-α and its receptors pattern expression in cows from a region characterized by extreme climatic seasonality. Animals were evaluated in three periods: spring (nâ¯=â¯15), summer (nâ¯=â¯14) and autumn (nâ¯=â¯11). Meteorological records from a local station were used to estimate the temperature and humidity index (THI) by means of an equation previously defined. A THI higher than 68 is indicative of stressing conditions. During the summer period, the animals were exposed to 8.5⯱â¯1.09â¯h of heat stress, or THIâ¯>â¯68. In spring, stress hours were reduced to 1.4⯱â¯0.5 every day, while during the autumn, there were no recorded heat stress events. Expression of TNF-α, and its receptors was determined by qPCR. During the summer, TNF-α and its receptors expression diminished drastically compared to the rest of the year, when stressful conditions were infrequent. We conclude that animals that are not physiologically prepared to resist high temperatures might have a less efficient immune response, reinforcing the need to develop new strategies to improve animal welfare.
Sujet(s)
Troubles dus à la chaleur/immunologie , Troubles dus à la chaleur/médecine vétérinaire , Réaction de choc thermique/génétique , Réaction de choc thermique/immunologie , Récepteurs aux facteurs de nécrose tumorale/génétique , Facteur de nécrose tumorale alpha/génétique , Animaux , Bovins , Maladies des bovins/immunologie , Femelle , Troubles dus à la chaleur/génétique , Température élevée , Humidité , Lactation , Agranulocytes/immunologie , Récepteurs aux facteurs de nécrose tumorale/immunologie , Saisons , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Anti-inflammatory effect of soluble secreted compounds of probiotic bacteria was widely demonstrated as therapy for different inflammatory diseases, but was not investigated in inflammatory eye disorders. The aim of this study was to determine whether Lactiplantibacillus plantarum CRL759 cell-free supernatant reduced inflammatory parameters and clinical signs in ocular inflammations. First, we evaluated the effect of L. plantarum CRL759 supernatant in vitro on human retinal cell line, ARPE-19 cells, stimulated with lipopolysaccharide (LPS). Then, we investigated in vivo its capacity to decrease inflammation by local administration on the eyes of mice with endotoxin induced inflammation. In vitro assays demonstrated that L. plantarum CRL759 supernatant reduced the production of interleukin (IL)-6, IL-8, nitric oxide and thiobarbituric acid reactive substances in LPS-stimulated ARPE-19 cells. Our in vivo data proved that L. plantarum supernatant significantly reduced the clinical score of endotoxin treated mice and diminished levels of tumour necrosis factor alpha, interferon gamma and protein concentration in aqueous humour. Histological examination showed reduction of infiltrating inflammatory cells in the posterior segment of the eyes. As far as we know, this is the first report showing that Lactobacillus spp. supernatant administered as drops reduces some parameters of ocular inflammation. This promising strategy is safe and could alleviate symptoms and signs of ocular inflammation in people that are refractories to the conventional therapies.
Sujet(s)
Maladies de l'oeil/traitement médicamenteux , Maladies de l'oeil/immunologie , Probiotiques/administration et posologie , Animaux , Modèles animaux de maladie humaine , Évaluation préclinique de médicament , Maladies de l'oeil/étiologie , Maladies de l'oeil/génétique , Femelle , Humains , Interleukine-6/génétique , Interleukine-6/immunologie , Interleukine-8/génétique , Interleukine-8/immunologie , Lactobacillus plantarum/physiologie , Lipopolysaccharides/effets indésirables , Mâle , Souris , Souris de lignée C57BL , Solutions ophtalmiques/administration et posologie , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
INTRODUCTION: The growing incidence of non-tuberculous mycobacteria (NTM) and changes in epidemiological factors have indicated that immune dysregulation may be associated with the emergence of NTM. Minireview entails to acknowledge complex interaction and new ways NTM are evolving around diverse immune status. METHODS: In order to perform this review, we selected peer reviewed, NLM database articles under the terms NTM, mycobacterium complex 'AND' -Host- immune response, immunity regulation, Disease, Single Nucleotide Polymorphism (SNP´s), and -pathogen- followed by a snow ball rolling basis search on immune components and NTM related with diseases distribution. RESULTS: The universal exposure and diversity of NTM are well-documented; however, hospitals seldom establish vigilant control of water quality or immunodeficiencies for patients with NTM infections. Depending on the chemical structures and immune mechanisms presented by various NTM varieties, they can trigger different effects in dendritic and natural killer cells, which release interleukin (IL)-17, tumour necrosis factor-α (TNF-α), interferon-γ (IFN-γ) and rIL-1B. The T helper (Th)2-acquired immune response is responsible for autoimmune responses in patients with NTM infections, and, quite disturbingly, immunocompetent patients have been reported to suffer from NTM infections. CONCLUSION: New technologies and a comprehensive view has taught us; to acknowledge metabolic/immune determinants and trade-offs along transit through mutualism-parasite continuous.
Sujet(s)
Immunité innée/immunologie , Mycobactéries non tuberculeuses/immunologie , Virulence/immunologie , Animaux , Humains , Interféron gamma/immunologie , Interleukine-17/immunologie , Interleukine-1 bêta/immunologie , Cellules tueuses naturelles/immunologie , Lymphocytes auxiliaires Th2/immunologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Allergic contact dermatitis (ACD) is a common allergic skin disease that affects individuals subjected to different antigen exposure conditions and significantly impacts the quality of life of those affected. Numerous studies have demonstrated that probiotics suppress inflammation through immunomodulatory effects. In this study, we aimed to evaluate the effect of the probiotic Bifidobacterium longum 51A as a preventive treatment for ACD using an oxazolone-induced murine model. We demonstrated that B. longum 51A exerted a prophylactic effect on oxazolone-induced ACD-like skin inflammation via reductions in ear and dermal thickness and leucocyte infiltration. The administration of inactivated B. longum 51A did not affect oxazolone-induced ACD-like skin inflammation, suggesting that the bacteria must be alive to be effective. Given that B. longum 51A is an acetate producer, we treated mice with acetate intraperitoneally, which also prevented ear and dermal thickening. Moreover, the tissue levels of the inflammatory cytokines and chemokines interleukin (IL)-10, IL-33, tumour necrosis factor-α, chemokine (C-C motif) ligand 2/monocyte chemoattractant protein-1 and chemokine (C-C motif) ligand 5/RANTES were significantly reduced after probiotic treatment, but only IL-33 and IL-10 were reduced when the mice were treated with acetate. These results show that B. longum 51A exerted a potential prophylactic effect on skin inflammation and that acetate represents one potential mechanism. However, other factors are likely involved since these two treatments do not yield the same results.
Sujet(s)
Bifidobacterium longum/physiologie , Eczéma de contact allergique/immunologie , Eczéma de contact allergique/prévention et contrôle , Probiotiques/administration et posologie , Animaux , Cytokines/génétique , Cytokines/immunologie , Eczéma de contact allergique/étiologie , Eczéma de contact allergique/génétique , Femelle , Humains , Interleukine-10/génétique , Interleukine-10/immunologie , Interleukine-33/génétique , Interleukine-33/immunologie , Souris , Souris de lignée BALB C , 4-Éthoxyméthylène-2-phényl-oxazol-5(4H)-one/effets indésirables , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
BACKGROUND: Anti-inflammatory properties have been attributed to latex proteins of the medicinal plant Calotropis procera. PURPOSE: A mixture of cysteine peptidases (LPp2) from C. procera latex was investigated for control of inflammatory mediators and inflammation in a mouse model of Salmonella infection. METHODS: LPp2 peptidase activity was confirmed by the BANA assay. Cytotoxicity assays were conducted with immortalized macrophages. Peritoneal macrophages (pMØ) from Swiss mice were stimulated with lipopolysaccharide (LPS) in 96-well plates and then cultured with nontoxic concentrations of LPp2. Swiss mice intravenously received LPp2 (10 mg/kg) and then were challenged intraperitoneally with virulent Salmonella enterica Ser. Typhimurium. RESULTS: LPp2 was not toxic at dosages lower than 62.2 µg/mL. LPp2 treatments of pMØ stimulated with LPS impaired mRNA expression of pro-inflammatory cytokines IL-1ß, TNF-α, IL-6 and IL-10. LPp2 increased the intracellular bacterial killing in infected pMØ. Mice given LPp2 had a lower number of leukocytes in the peritoneal cavity in comparison to control groups 6 h after infection. The bacterial burden and histological damage were widespread in target organs of mice receiving LPp2. CONCLUSION: We conclude that LPp2 contains peptidases with strong anti-inflammatory properties, which may render mice more susceptible to early disseminated infection caused by Salmonella.
Sujet(s)
Anti-inflammatoires/pharmacologie , Calotropis/composition chimique , Peptide hydrolases/pharmacologie , Protéines végétales/pharmacologie , Salmonelloses/traitement médicamenteux , Salmonella typhimurium/effets des médicaments et des substances chimiques , Animaux , Anti-inflammatoires/isolement et purification , Régulation de l'expression des gènes , Interleukine-10/génétique , Interleukine-10/immunologie , Interleukine-1 bêta/génétique , Interleukine-1 bêta/immunologie , Interleukine-6/génétique , Interleukine-6/immunologie , Latex/composition chimique , Lipopolysaccharides/antagonistes et inhibiteurs , Lipopolysaccharides/pharmacologie , Macrophages péritonéaux/effets des médicaments et des substances chimiques , Macrophages péritonéaux/immunologie , Souris , Peptide hydrolases/isolement et purification , Parties aériennes de plante/composition chimique , Extraits de plantes/composition chimique , Protéines végétales/isolement et purification , Plantes médicinales , Culture de cellules primaires , Salmonelloses/immunologie , Salmonelloses/microbiologie , Salmonelloses/anatomopathologie , Salmonella typhimurium/immunologie , Salmonella typhimurium/pathogénicité , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Pharmacological treatment of osteoarthritis is still inadequate due to the low efficacy of the drugs used. Dexmedetomidine via the intra-articular (i.a.) route might be an option for the treatment of osteoarthritis-associated pain. The present study assessed the analgesic and anti-inflammatory effects of dexmedetomidine administered via the i.a. route in different doses in an experimental model of rat knee osteoarthritis induced with monosodium iodoacetate. Rats were allocated to four groups with 24 animals in each group. The OA (osteoarthritis), DEX-1 (dexmedetomidine in dose of 1µg/kg) and DEX-3 (dexmedetomidine in dose of 3µg/kg) groups were subjected to induction of osteoarthritis through injection of monosodium iodoacetate (MIA) via the i.a. route on the right knee; the control group was not subjected to osteoarthritis induction. Clinical assessment was performed on day 0 (before osteoarthritis induction) and then on days 5, 10, 14, 21 and 28 after induction. Treatment was performed on day 7 via the i.a. route, consisting of dexmedetomidine in doses of 1 and 3 µg/kg, while group OA received 0.9% normal saline. The animals were euthanized on days 7, 14, 21 and 28. Samples of the synovial membrane were collected for histopathological analysis, and the popliteal lymph nodes were collected for measurement of cytokines (interleukin [IL] IL-6, tumor necrosis factor alpha [TNF-α]). Dexmedetomidine (1 and 3 µg/kg) significantly reduced the animals' weight distribution deficit during the chronic-degenerative stage of osteoarthritis and improved the pain threshold throughout the entire experiment. Histological analysis showed that dexmedetomidine did not cause any additional damage to the synovial membrane. The TNF-α levels decreased significantly in the DEX-3 group on day 28 compared with the OA group. Dexmedetomidine reduced pain, as evidenced by clinical parameters of osteoarthritis in rats, but did not have an anti-inflammatory effect on histological evaluation.
Sujet(s)
Cartilage articulaire/immunologie , Dexmédétomidine/pharmacologie , Interleukine-6/immunologie , Arthrose/traitement médicamenteux , Membrane synoviale/immunologie , Facteur de nécrose tumorale alpha/immunologie , Animaux , Cartilage articulaire/anatomopathologie , Modèles animaux de maladie humaine , Injections articulaires , Mâle , Arthrose/induit chimiquement , Arthrose/immunologie , Arthrose/anatomopathologie , Rats , Rat Wistar , Membrane synoviale/anatomopathologieRÉSUMÉ
INTRODUCTION: Studies have suggested that an inappropriate inflammatory response is a major cause of treatment failure and mortality in patients with community-acquired pneumonia (CAP). We aimed to determine the effect of age and comorbidities on serum inflammatory markers in CAP. METHODS: We performed a prospective cohort study of adults hospitalized with CAP. For the purposes of this study, we compared patients according to comorbidities and age. Inflammatory markers were measured at hospital admission, focusing on acute phase proteins, cytokines and monocyte human leucocyte antigen DR (mHLA-DR) expression. RESULTS: In patients with chronic pulmonary disease (COPD), serum cytokines had significantly decreased levels of tumour necrosis factor (TNF)-α, interleukin (IL)-6 and mHLA-DR expression, as well as the C-reactive protein (CRP), compared with patients who had no comorbidities. Similarly, patients with chronic heart disease had a significantly reduced CRP levels and mHLA-DR expression, whereas patients with chronic kidney disease had significantly higher serum levels of procalcitonin and TNF-α. Lower procalcitonin, IL-6 and IL-10 levels, as well as mHLA-DR expression, were documented in older patients, but with no significant differences compared to younger patients. Multimorbidity in older patients was associated with significant lower levels of CRP and mHLA-DR expression. CONCLUSIONS: The circulating inflammatory markers to CAP have profiles that differ with age and underlying comorbidities. Multimorbidity in the elderly is also associated with lower serum levels of some inflammatory markers. Our findings suggest that inflammatory markers in CAP should be interpreted after considering age and comorbid conditions.
Sujet(s)
Infections communautaires/sang , Cytokines/sang , Pneumopathie infectieuse/sang , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Protéine C-réactive/immunologie , Protéine C-réactive/métabolisme , Études de cohortes , Infections communautaires/épidémiologie , Infections communautaires/immunologie , Comorbidité , Cytokines/immunologie , Femelle , Antigènes HLA-DR/immunologie , Cardiopathies/épidémiologie , Hospitalisation , Humains , Interleukine-10/sang , Interleukine-10/immunologie , Interleukine-6/sang , Interleukine-6/immunologie , Mâle , Adulte d'âge moyen , Monocytes/immunologie , Pneumopathie infectieuse/épidémiologie , Pneumopathie infectieuse/immunologie , Procalcitonine/sang , Procalcitonine/immunologie , Études prospectives , Broncho-pneumopathie chronique obstructive/épidémiologie , Insuffisance rénale chronique/épidémiologie , Facteur de nécrose tumorale alpha/sang , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Neospora caninum is a protozoan associated with abortions in ruminants and neuromuscular disease in dogs. Classically, the immune response against apicomplexan parasites is characterized by the production of proinflammatory cytokines, such as IL-12, IFN-γ and TNF. TNF is mainly produced during the acute phases of the infections and binds to TNF receptor 1 (CD120a, p55, TNFR1) activating a variety of cells, hence playing an important role in the induction of the inflammatory process against diverse pathogens. Thus, in this study, we aimed to evaluate the role of TNF in cellular and humoral immune responses during N. caninum infection. For this purpose, we used a mouse model of infection based on wildtype (WT) and genetically deficient C57BL/6 mice in TNFR1 (Tnfr1-/-). We observed that Tnfr1-/- mice presented higher mortality associated with inflammatory lesions and increased parasite burden in the brain after the infection with N. caninum tachyzoites. Moreover, Tnfr1-/- mice showed a reduction in nitric oxide (NO) levels in vivo. We also observed that Tnfr1-/- mice showed enhanced serum concentration of antigen-specific IgG2 subclass, while IgG1 production was significantly reduced compared to WT mice, suggesting that TNFR1 is required for regular IgG subclass production and antigen recognition. Based on our results, we conclude that the TNF-TNFR1 complex is crucial for mediating host resistance during the infection by N. caninum.
Sujet(s)
Coccidiose , Neospora , Récepteur au facteur de nécrose tumorale de type I , Facteur de nécrose tumorale alpha/immunologie , Animaux , Coccidiose/immunologie , Cytokines , Femelle , Souris , Souris de lignée C57BL , Souris knockout , Grossesse , Récepteur au facteur de nécrose tumorale de type I/immunologieRÉSUMÉ
Imbalance in the immune response is one of the main pathogenic mechanisms of diseases related with human immunodeficiency virus (HIV)/human gammaherpesvirus 8 (HHV-8) coinfection, such as Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman disease (MCD) and the Kaposi's sarcoma-associated herpesvirus inflammatory cytokine syndrome (KICS). However, significant changes in pro- and anti-inflammatory cytokine levels may be observed in HIV/HHV-8 individuals who are negative for KS, PEL, MCD, and/or KICS. In this study, serum levels of interleukin-2 (IL-2), IL-4, IL-6, IL-10, tumor nucrosis factor α (TNF-α) and interferon γ (IFN-γ) were assessed in 69 HIV and 48 HIV/HHV-8 individuals, all negatives for HHV-8-related diseases. The cytokines were measured by flow cytometry and analyzed by the Mann-Whitney test. The p < .05 and 95% confidence interval were considered in all analyzes. IL-4 (p = .0155), IL-6 (p = .0036), and IL-10 (p = .0036) levels were significantly higher in HIV/HHV-8 patients than in the HIV group. On the other hand, IL-2 (p = .2295), TNF-α (p = .1216) and IFN-γ (p = .1178) did not differ between the groups analyzed. To our knowledge, to date, this is the first report on significant differences in the levels of IL-4 and IL-6 in HIV versus HIV/HHV-8 individuals. Finally, these early findings are important as a prognostic tool and contribute to clarifying the HHV-8-host interaction.
Sujet(s)
Cytokines/génétique , Cytokines/immunologie , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Infections à Herpesviridae/immunologie , Herpèsvirus humain de type 8/immunologie , Interféron gamma/génétique , Facteur de nécrose tumorale alpha/génétique , Adulte , Études cas-témoins , Cytokines/classification , Femelle , Infections à VIH/sang , Infections à VIH/virologie , Infections à Herpesviridae/sang , Infections à Herpesviridae/virologie , Interactions hôte-microbes/immunologie , Humains , Interféron gamma/immunologie , Mâle , Adulte d'âge moyen , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
LQFM219 is a molecule designed from celecoxibe (COX-2 inhibitor) and darbufelone (inhibitor of COX-2 and 5-LOX) lead compounds through a molecular hybridisation strategy. Therefore, this work aimed to investigate the antinociceptive and anti-inflammatory activities of this new hybrid compound. The acute oral systemic toxicity of LQFM219 was evaluated via the neutral red uptake assay. Acetic acid-induced abdominal writhing and CFA-induced mechanical hyperalgesia were performed to evaluate the antinociceptive activity, and the anti-oedematogenic activity was studied by CFA-induced paw oedema and croton oil-induced ear oedema. Moreover, the acute anti-inflammatory activity was determined by carrageenan-induced pleurisy. In addition, cell migration, myeloperoxidase enzyme activity, and TNF-α and IL-1ß levels were determined in pleural exudate. Moreover, a redox assay was conducted using electroanalytical and DPPH methods. The results demonstrated that LQFM219 was classified as GHS category 4, and it showed better free radical scavenger activity compared to BHT. Besides, LQFM219 decreased the number of writhings induced by acetic acid and the response to the mechanical stimulus in the CFA-induced mechanical hyperalgesia test. Furthermore, LQFM219 reduced oedema formation, cell migration, and IL-1ß and TNF-α levels in the pleural cavity and inhibited myeloperoxidase enzyme activity. Thus, our study provides that the new pyrazole derivative, LQFM219, demonstrated low toxicity, antinociceptive and anti-inflammatory potential in vitro and in vivo.
Sujet(s)
Analgésiques/usage thérapeutique , Anti-inflammatoires/usage thérapeutique , Antioxydants/usage thérapeutique , Acide acétique , Analgésiques/pharmacologie , Animaux , Anti-inflammatoires/pharmacologie , Antioxydants/pharmacologie , Cellules BALB 3T3 , Carragénane , Huile de croton , Oedème/induit chimiquement , Oedème/traitement médicamenteux , Adjuvant Freund , Hyperalgésie/induit chimiquement , Hyperalgésie/traitement médicamenteux , Interleukine-1 bêta/immunologie , Mâle , Souris , Douleur/induit chimiquement , Douleur/traitement médicamenteux , Stimulation physique , Plèvre/immunologie , Pleurésie/induit chimiquement , Pleurésie/traitement médicamenteux , Pleurésie/immunologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
BACKGROUND: Low molecular weight carrageenan (Cg) is a seaweed-derived sulfated polysaccharide widely used as inflammatory stimulus in preclinical studies. However, the molecular mechanisms of Cg-induced inflammation are not fully elucidated. The present study aimed to investigate the molecular basis involved in Cg-induced macrophages activation and cytokines production. METHODS: Primary culture of mouse peritoneal macrophages were stimulated with Kappa Cg. The supernatant and cell lysate were used for ELISA, western blotting, immunofluorescence. Cg-induced mouse colitis was also developed. RESULTS: Here we show that Cg activates peritoneal macrophages to produce pro-inflammatory cytokines such as TNF and IL-1ß. While Cg-induced TNF production/secretion depends on TLR4/MyD88 signaling, the production of pro-IL-1ß relies on TLR4/TRIF/SYK/reactive oxygen species (ROS) signaling pathway. The maturation of pro-IL1ß into IL-1ß is dependent on canonical NLRP3 inflammasome activation via Pannexin-1/P2X7/K+ efflux signaling. In vivo, Cg-induced colitis was reduced in mice in the absence of NLRP3 inflammasome components. CONCLUSIONS: In conclusion, we unravel a critical role of the NLRP3 inflammasome in Cg-induced pro-inflammatory cytokines production and colitis, which is an important discovery on the pro-inflammatory properties of this sulfated polysaccharide for pre-clinical studies. Video abstract Carrageenan (Cg) is one the most used flogistic stimulus in preclinical studies. Nevertheless, the molecular basis of Cg-induced inflammation is not totally elucidated. Herein, Lopes et al. unraveled the molecular basis for Cg-induced macrophages production of biological active IL-1ß. The Cg-stimulated macrophages produces pro-IL-1ß depends on TLR4/TRIF/Syk/ROS, whereas its processing into mature IL-1ß is dependent on the canonical NLRP3 inflammasome.